Histone deacetylase, and uses therefor

Details Histone deacetylase, and uses therefor Histone deacetylase, and uses therefor

2000-08-11

2004-01-06

Saidha, Tekchand (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S006120, C435S007100, C435S252300, C435S320100, C536S023200, C530S350000

Reexamination Certificate

active

06673587

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to the identification, isolation, sequencing and characterization of a new member of the histone deacetylase family, as well as its transcripts, gene products, associated sequence information, and related genes. The present invention also relates to methods for detecting and diagnosing carriers of normal and mutant alleles of these genes, methods for detecting and diagnosing diseases, methods of identifying genes and proteins related to or interacting with such genes and proteins, methods of screening for potential therapeutics for diseases, methods of treatment for diseases, and cell lines and animal models useful in screening for and evaluating potentially useful therapies for diseases. In a particular aspect of the present invention, a novel family member, HDAC7, is described, and its interaction with SMRT/N-CoR and mSin3A, its biochemical properties and subcellular localization are all characterized. In addition, evidence is provided that the HDAC4, 5, and 7 deacetylases mediate nuclear receptor repression. The findings described here indicate that two or more classes of hi stone deacetylases can collectively contribute to SMRT/N-CoR action and that at least some deacetylases may directly associate with SMRT/N-CoR in an mSin3A independent fashion.
BACKGROUND OF THE INVENTION
Nuclear hormone receptors are sequence-specific and ligand-dependent transcription factors that control cell proliferation, differentiation, and animal physiology (Mangelsdorf and Evans, (1995) Cell, 83:841-850; Mangelsdorf et al., (1995) Cell, 83:835-839). They are structurally related and contain two evolutionarily conserved modules, the DNA binding (DBD) and ligand-binding domains (LBD). Several receptors including retinoic acid and thyroid hormone receptors function as potent repressors in the absence of ligands and as activators upon ligand binding. Intensive studies on the mechanism of transcriptional activation by nuclear hormone receptors led to the identification of coactivators including CBP/p300, PCAF, as well as the p160 family proteins (SRC-1; GRIP1/TIF2; ACTR/RAC3/P/CIP) (Blanco et al., (1998) Genes & Devel., 12:1638-51; Chen et al., (1997) Cell, 90:569-80; Hong et al., (1996) Proc. Natl. Acad. Sci. USA, 93:4948-52; Kamei et al., (996) Cell, 85: 403-414; Onate et al., (1995) Science, 270:1354-57; Torchia et al., (1997) Nature, 387:677-84; Yao et al., (1996) Proc. Nati. Acad. Sci. USA, 93:10626-31). Among these, CBP, PCAF, and SRC-1/ACTR have been recently shown to possess intrinsic histone acetyltransferase activity, consistent with a role for histone acetylation in transcriptional activation (Bannister and Kouzarides, (1996) Nature, 384:641-43; Chen et al., (1997) Cell, 90:569-80; Ogryzko et al., (1996) Cell, 87:953-59; Spencer et al., (1997) Nature, 389:194-98; Yang et al., (1996) Nature, 382:12845-50).
Several corepressors for nuclear receptors including SMRT, N-CoR, SUN-CoR, and Alien have also been identified (Chen and Evans, (1995) Nature, 377:454-57; Dressel et al., (1999) Cell. Blo., 19:3383-94; Horlein et al., (1995) Nature, 377:397-404; Ordentlich et al., (1999) Proc. Natl. Acad. Sci. USA, 96:2639-44; Zamir et al., (1996) Mol. Cell. Biol., 16:5458-65). SMRT and N-CoR were identified by yeast two-hybrid screens with nuclear receptors. Both proteins are large and possess at least four autonomous repression domains.
In addition to nuclear receptors, functional associations between SMRT/N-CoR with other transcription factors including CBF1/RBPJK, PLZF, BCL6, MyoD, Bach2, and Pbx1 have been demonstrated (Asahara et al., (1999) Mol. Cell. Biol., in press; Bailey et al., (1999) Mol. Endocrinol., 13:1155-68; Dhordain et al., (1997) Proc. Natl. Acad. Sci. USA, 94:10762-67; He et al., (1998) Nat Genet 18:126-35; Hong et al., (1997) Proc. Natl. Acad. Sci. USA, 94:9028-33; Huynh and Bardwell, (1998) Oncogene, 17:2473-84; Kao et al., (1998) Genes & Devel. 12:2269-77; Lin et al., (1998) Nature, 391:811-14; Muto et al., (1998) EMBO J., 17:5734-43; Wong and Privalsky, (1998) J. Biol. Chem., 273:27695-702), suggesting that corepressors, like coactivators, may function as signaling integrators to control cell fate. Several lines of evidence suggest that the mechanism underlying the repressive activity of SMRT and N-CoR corepressors is manifested through their recruitment of a histone deacetylase complex containing mSin3A and HDAC1 (Alland et al., (1997) Nature, 387:49-55; Hassig et al., (1997) Cell, 89:341-47; Heinzel et al., (1997) Nature, 387:43-48; Laherty et al., (1997) Cell, 89-349-56; Nagy et al., (1997) Cell, 89:373-80; Zhang et al., (1997) Cell, 357-64). Recruitment of acetylase/deacetylase complexes by coactivators/corepressors is thought to cause a local change in the chromatin structure, resulting in either activation or repression of gene transcription.
In yeast Sacchromyces cerevisiae, two distinct histone deacetylase complexes have been characterized (Carmen et al., (1996) J. Biol. Chem., 271:15837-44; Rundlett et al., (1996) Proc. Natl. Acad. Sci. USA, 93:14503-08). Histone deacetylase-B (HDB) is a 600 kDa complex which contains the Rpd3 protein. Histone deacetylase-A (HDA) is a 350 kDa complex and contains yeast Hda1 and the related Hos1, 2, and 3. Homology studies indicate that the HDA1-related deacetylases are structurally distinct from Rpd3 (which appears to be most related to mammalian class I deacetylases HDAC1, 2, and 3). Class II mammalian histone deacetylases (HDAC4, 5, and 6) have been recently identified which are structurally related to yeast Hda1 (Fischle et al., (1999) J. Biol. Chem., 274:11713-20; Grozinger et al., (1999) Proc. Natl, Acad. Sci. USA, 96:4868-73; Verdel and Khochbin, (1999) J. Biol. Chem., 2440-45). These family members are large in size (from 1085 amino acids to 1216 amino acids) and are able to deacetylate histones in vitro. HDAC4 and HDAC5 (also known as mHDA1) are highly homologous (51%/63% in identity/homology) and contain a conserved C-terminal deacetylase domain (89% amino acid identity). Intriguingly, HDAC6 (also known as mHDA2) has two catalytic domains at the amino-terminal, which have been suggested to form an intramolecular dimer. While HDAC4 has been shown to coprecipitate with HDAC3 and RbAp48, HDAC5 appears to associate with at least HDAC3 (Grozinger et al., 1999, supra). Furthermore, Northern blot analyses indicate that the tissue distribution patterns of family members are quite distinct. Numerous studies have indicated that the HDAC1/HDAC2 complexes are recruited to promoters by sequence-specific DNA-binding transcription factors (Doetzlhofer et al., (1999) Mol. Cell. Biol., 19:5504-11; Emiliani et al., (1998) Proc. Natl. Acad. Sci. USA, 95:2795-800; lavarone and Massague, (1999) Mol. Cell. Biol., 19:916-22; Radkov et al., (1999) J. Virol., 73:5688-97; Yang et al., (1996)). A recent report suggests that HDAC4 associates with and represses the MEF2 transcription factor (Miska et al., (1999) EMBO J., 18:5099-5107). However, the role of the HDAC4-6 family of histone deacetylases in transcription is largely unknown.
A key event in the regulation of eukaryotic gene expression is the posttranslational modification of nucleosomal histones, which converts regions of chromosomes into transcriptionally active or inactive chromatin. The most well studied posttranslational modification of histones is the acetylation of epsilon-amino groups on conserved lysine residues in the histones' amino-terminal tail domains. Histone acetylation influences both gene transcription and chroma tin assembly after DNA replication and the enzymes that regulate this property of chromatin are likely to play a key role in regulating these crucial genomic functions. The steady-state level of histone acetylation is established and maintained by multiple histone acetyltransferases (HATs) and deacetylases (HDACs). Significant advances have been made in the past few years toward the identification of histone acetyltransferases and histone deacetylases.
The HDACs have been implicated in repression of gene expression

Affiliated with

Also associated with

Rating

Histone deacetylase, and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Histone deacetylase, and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histone deacetylase, and uses therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3188360